The clinical trial conducted by My Goodlife SAS evaluated the effectiveness of health-connected devices and internet-based follow-up in enhancing physical activity recovery in obese patients post-bariatric surgery. Given the rising prevalence of obesity and the increasing demand for digital health solutions, this trial positions My Goodlife SAS favorably within the growing digital therapeutics market. The competitive landscape includes other digital health platforms focusing on obesity management, necessitating a strong differentiation strategy. The results may support potential partnerships with healthcare providers and payers, enhancing market access and reimbursement opportunities.